Cloprostenol as an Inductor in Feline Pregnancy
World Small Animal Veterinary Association World Congress Proceedings, 2004
Canooglu, E1, Demiral O.2, Bekyurek, T.1, Atabay, Ö.3, Akar İ.3
1Department for Obstetrics and Gynecology, Faculty of Veterinary Medicine, University of Erciyes, Kayseri, Turkey; 2Department for Artificial Insemination and Andrology, Faculty of Veterinary Medicine, University of Erciyes, Kayseri, Turkey; 3Health Science Institute, Faculty of Veterinary Medicine, University of Erciyes, Kayseri, Turkey

In this preliminary study we investigated a synthetic prostaglandin analog for induction of both abortion and parturition. The purpose of the present report is to evaluate the effect of cloprostenol in pregnant queens with unavailable medical histories.

In order to determine the abortifacient effect of cloprostenol, 3 queens were given daily dosages of 2.25 µg of d-cloprostenol (Dalmazin®, Vetas, Istanbul, Turkey) / kg of body weight, subcutaneously until abortion was completed. Cloprostenol was also applied for evaluation of effectiveness on the induction of parturition in 2 queens using the same dosage and means.

Termination of pregnancy was successful in 2 of the 3 queens treated with cloprostenol. Two queens were aborted 2 and 5 days after the first treatment, whereas treatment failed in the 3rd queen. The parturitions were started 45 minutes and 2 hours after the administrations and completed in 45 minutes and 6 hours respectively. Most common side effects included an increase of pulmonary rate, restlessness, abdominal pain, and vocalization.

In conclusion, cloprostenol alone may provide benefits in the termination of feline pregnancy.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

E. Canooglu
Department for Obstetrics and Gynecology
Faculty of Veterinary Medicine, University of Erciyes
Kayseri, Turkey


MAIN : Abstracts : Cloprostenol in Feline Pregnancy
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27